Castle Creek Biosciences, Inc.

Castle Creek Biosciences, Inc. is a pioneering regenerative medicine company dedicated to creating transformative therapies for genetic diseases, with a particular focus on improving the lives of patients suffering from severe skin and connective tissue disorders. Castle Creek Biosciences is committed to innovation and excellence in biotechnology research, striving to deliver groundbreaking treatments that address unmet medical needs.

Located at 405 Eagleview Blvd, Exton, Pennsylvania 19341, US, Castle Creek Biosciences is launching a pivotal clinical trial for patients with dystrophic epidermolysis bullosa (DEB), reflecting its dedication to advancing clinical research and providing hope for individuals with rare diseases. The company's commitment extends to personalized medicine, drug development, and gene therapy, positioning Castle Creek Biosciences as a leader in the life sciences industry.

Castle Creek Biosciences is dedicated to making a significant impact on pediatric disease treatment and genetics through its robust research and development programs. We invite the management of Castle Creek Biosciences, Inc. to create a customized and exclusive company showcase and product listing on our platform, highlighting their innovative work and expanding their reach to a global audience.